The First Phase 3 Success for Psychedelics Will Pave the Way for an Industry

The First Phase 3 Success for Psychedelics Will Pave the Way for an Industry
·5 min read

Psychotherapy combined with doses of the illegal drug known as Ecstasy gave dramatic relief to sufferers of post-traumatic stress syndrome. Investors are pouring money in psychedelic drug developers, but the study was backed by a nonprofit.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting